Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CTLA-4 variant immunomodulatory proteins and uses thereof

CTLA-4 variant immunomodulatory proteins and uses thereof

US Patent 11753458 · Granted Sep 12, 2023

Estimated economic value: $8,298,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunomodulatory proteins with tunable affinities2025
Interferon alpha-2 variants2025
CTLA-4 variant immunomodulatory proteins and uses thereof2025
CTLA-4 variant immunomodulatory proteins and uses thereof2025
CTLA-4 variant immunomodulatory proteins and uses thereof2025
April and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
April and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
Multi-domain immunomodulatory proteins and methods of use thereof2025
Interleukin 21 variants2025
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
ICOS ligand variant immunomodulatory proteins and uses thereof2024